Aug 7, 2023, 07:17
Promising strides in Ovarian Cancer research! – Henry Rodriguez
Promising strides in Ovarian Cancer research! CPTAC has identified a 64-protein signature that may predict which patients do not respond to chemotherapy. This novel protein signature may save patients from unnecessary toxic side effects and is a promising step toward personalized therapy and better outcomes.
For the article: Click here
Source: Henry Rodriguez / Linkedin
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Nov 12, 2024, 23:10
Nov 12, 2024, 23:07
Nov 12, 2024, 22:58
Nov 12, 2024, 22:56
Nov 12, 2024, 22:50
Nov 12, 2024, 22:46
Nov 12, 2024, 22:43